{"id":3924,"date":"2018-10-26T09:41:52","date_gmt":"2018-10-26T07:41:52","guid":{"rendered":"http:\/\/www.seventure.fr\/?p=3924"},"modified":"2018-11-19T18:17:06","modified_gmt":"2018-11-19T17:17:06","slug":"galecto-biotech-raises-e79-million-in-series-c-financing-co-led-by-ysios-capital-and-orbimed-to-advance-galectin-inhibitor-to-late-stage-clinical-development","status":"publish","type":"post","link":"https:\/\/www.seventure.fr\/en\/galecto-biotech-raises-e79-million-in-series-c-financing-co-led-by-ysios-capital-and-orbimed-to-advance-galectin-inhibitor-to-late-stage-clinical-development\/","title":{"rendered":"Galecto Biotech Raises \u20ac79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[101,106],"tags":[],"class_list":["post-3924","post","type-post","status-publish","format-standard","hentry","category-life-sciences-en","category-biotech-pharmaceuticals"],"acf":[],"yoast_head":"\n